2 completed, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow lorecivivint: new trials by email Literature Review of lorecivivint trials Research Report on lorecivivint
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers Lorecivivint (LOR), Triamcinolone acetonide (TA) - Drug-Drug Interaction | Phase 1 | Completed | Biosplice Therapeutics, Inc. | 40 | 2020-10-13 | 2021-01-12 |
| A Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in Subjects With Degenerative Disc Disease SM04690 - Degenerative Disc Disease | Phase 1 | Terminated | Biosplice Therapeutics, Inc. | 6 | 2017-07-26 | 2019-04-23 |
| Phase 1, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SM04690 in Moderate to Severe Knee Osteoarthritis (OA) SM04690, 0.03mg/2mL, SM04690, 0.07mg/2mL, SM04690, 0.23mg/2mL - Moderate to Severe Osteoarthritis | Phase 1 | Completed | Biosplice Therapeutics, Inc. | 61 | 2014-03-01 | 2015-12-10 |
Intervertebral Disc Degeneration (1)
Biosplice Therapeutics, Inc. (3)
United States (3)